Neurology® Podcast
Dr. Andy Southerland talks with Dr. Lidia Moura about the implications of large language models (LLMs) for neurologic care. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Drs. Michael R. Wilson and John Pluvinage about their discovery of anti-CD320 antibodies in patients with neurologic manifestations of B12 deficiency and discuss the potential implications for diagnosis and treatment. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Jason Crowell talks with Dr. Campbell Le Heron about the association of clinical and neurocognitive factors with apathy in patients with Parkinson disease. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Andrew McKeon about the topic of autoimmune neurology, specifically focusing on the antibody CAMKV and its association with autoimmune encephalitis. Read the related article in . Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Jessica Ailani talks with Dr. Ian Carroll about intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Read the related article in . This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at .
info_outlineNeurology® Podcast
As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Eric Seachrist about his experience with multiple sclerosis. This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Stacey Clardy talks with Dr. Carlayne E. Jackson about the state of neurology and the challenges and opportunities facing the field. This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at .
info_outlineNeurology® Podcast
Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference. Show references: This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at Neurology.org.
info_outlineNeurology® Podcast
The July 2024 replay of past episodes showcases four incredible interviews on infectious and post-infectious neurology. The episode begins with Dr. Alice Tang discussing the association between immune status and herpes simplex virus encephalitis. The episode leads into Dr. Haya Bishara talking about GBS and COVID-19 infection. In the third episode, Dr. Adam de Havenon talks about neurologic diagnoses in the year after COVID-19 vs. Influenza. The episode concludes with Dr. Avindra Nath talking about new research related to post-infectious myalgic encephalomyelitis/chronic fatigue syndrome....
info_outlineNeurology® Podcast
Dr. Tesha Monteith talks with Dr. Michael Marmura about the definition of refractory headache, the challenges in treating migraine, the role of comorbidities, and the importance of accurate diagnosis. This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at .
info_outlineThe September 2023 Neurology Recall showcases five dynamic interviews about ALS. The episode begins with a discussion about the strategic plan for ALS from the NINDS with Dr. Walter Korshetz. This episode features conversations with Drs. Ruben P.A. van Eijk-3 and Jordi van Unnik on simulation based interim analysis of ALS clinical trials followed by an interview with Dr. Emily Plowman on respiratory strength training (RST) programs in individuals with ALS. The episode continues with an interview with Dr. Suma Babu on the approved treatment for ALS associated with a mutation in the SOD1 gene. This month's Recall concludes with a conversation with Dr. Ajay Sampat on his story of being a neurologist diagnosed with ALS.
Related Articles:
- Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS
- Respiratory Strength Training in Amyotrophic Lateral Sclerosis
- FDA Approves Treatment of Amyotrophic Lateral Sclerosis Associated With a Mutation in the SOD1 Gene
Related Podcast:
- The ALS Strategic Plan from NINDS
- Simulation-Based Planning of ALS Trials
- Respiratory Strength Training in ALS
- FDA Approved Therapy for SOD1 Associated ALS
- A Neurologist’s Experience as a Patient with ALS
Visit NPUb.org/Podcast for associated article links.